PHARMARON 03759Hong Kong Stock Exchange

30.6002.11%( -0.660 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
PHARMARON (03759) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2019-11-28
Industry
CRO/CDMO
Fiscal Year End
Dec 31
ISIN
CNE100003PG4
Southbound Connect
Shanghai · Shenzhen

Related Securities

Industry

CRO/CDMO 0.25%
14 stocks in this industry
Down 8 Up 6
Industry RankingsValue (HKD)Rank
Revenue (Last FY)16.53B4/14
Net Profit (Last FY)1.95B3/14
ROE (Last FY)11.05%4/14

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
楼柏良 Executive Director
楼小强 Executive Director
郑北 Executive Director
李承宗 Executive Director
万璇 Non-Executive Director
李丽华 Independent Non-Executive Director
曾劲峰 Independent Non-Executive Director
沈蓉 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-06-15.

About this page

This page shows PHARMARON (03759) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.